Overview

Ondansetron for the Treatment of Cocaine Dependence - 1

Status:
Completed
Trial end date:
2002-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of ondansetron to reduce cocaine use in subjects with cocaine dependence.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
University of Texas
Treatments:
Cocaine
Ondansetron